Clinical Pharmacokinetics of 1-[((S)-2-Hydroxy-2-Oxo-1,4,2-Dioxaphosphorinan-5-yl)methyl]cytosine in Human Immunodeficiency Virus-Infected Patients

Por Cundy, Kenneth C., Barditch-Crovo, Patricia, Petty, Brent G., Ruby, April, Redpath, Murphy, Jaffe, Howard S., Lietman, Paul S.
Publicado no Antimicrob Agents Chemother (1999)

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)

Por Pahwa, Rajesh, Tanner, Caroline M., Hauser, Robert A., Sethi, Kapil, Isaacson, Stuart, Truong, Daniel, Struck, Lynn, Ruby, April E., McClure, Natalie L., Went, Gregory T., Stempien, Mary Jean
Publicado no Mov Disord (2015)